LTIMindtree [NSE: LTIM, BSE: 540005], a global provider of technology consulting and digital transformation services, has been chosen by Convatec, a worldwide leader in medical products and technologies, as its strategic partner for the rollout of SAP’s S/4HANA Digital Core. Under this partnership, LTIMindtree will guide the implementation of SAP S/4HANA across Convatec’s operations.
The initiative will update Convatec’s S/4HANA environment, simplify core processes, and support the shift toward intelligent, AI-enabled business operations. The enhanced platform will contribute to Convatec’s objectives around process harmonization and operational excellence, forming the technological backbone for the company’s next phase of transformation.
“We are pleased to select LTIMindtree, after a competitive assessment, to support our transition to SAP S/4HANA. Their expertise will help us advance our strategic agenda, improve efficiency, and enable future growth,” said Angie Goodwin, Chief Digital Information Officer at Convatec.
“We look forward to working with Convatec on this important modernization program. Our extensive experience with S/4HANA implementations, coupled with an AI-first approach, positions us well to deliver meaningful outcomes that advance Convatec’s growth strategy,” said Srini Rao, EVP and Chief Business Officer Europe at LTIMindtree. LTIMindtree will apply its deep knowledge of SAP S/4HANA and industry-specific best practices to help Convatec fully leverage the platform and achieve measurable operational improvements.
LTIMindtree is a global technology consultancy and digital solutions organization that collaborates with enterprises across sectors to reinvent business models, foster innovation, and drive AI-powered growth. The company serves more than 700 clients worldwide, delivering operational excellence, enhanced customer experiences, and sustainable long-term value. With over 86,000 professionals across more than 40 countries, LTIMindtree — part of the Larsen & Toubro Group — specializes in solving complex business challenges and executing transformations at scale.
Convatec is a global medical solutions company dedicated to supporting people with chronic conditions. Its portfolio spans Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, holding leading positions across these categories. With more than 10,000 employees and a presence in approximately 90 countries, Convatec is committed to improving patient outcomes while lowering care costs. In 2024, the company generated revenues exceeding $2 billion and is listed on the FTSE 100 Index (LSE: CTEC).
